<DOC>
	<DOCNO>NCT00000679</DOCNO>
	<brief_summary>To show zalcitabine ( dideoxycytidine ; ddC ) least effective zidovudine ( AZT ) treatment AIDS advance AIDS relate complex ( ARC ) , also ddC show different safety profile AZT . In clinical study , ddC show antiviral activity . Because antiviral activity , low incidence mild , reversible neurotoxicity absence blood-related toxicity low dose ddC therapy , long-term Phase II/III study compare ddC AZT patient AIDS advance ARC warrant .</brief_summary>
	<brief_title>( Ro 24-2027 ) A Randomized , Double-Blind , Comparative Study Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) Patients With AIDS Advanced ARC</brief_title>
	<detailed_description>In clinical study , ddC show antiviral activity . Because antiviral activity , low incidence mild , reversible neurotoxicity absence blood-related toxicity low dose ddC therapy , long-term Phase II/III study compare ddC AZT patient AIDS advance ARC warrant . After screen , physical examination laboratory test ( within 14 day entry ) patient randomize one two treatment group . They receive either ddC plus AZT placebo AZT plus ddC placebo . Because blind study , patient know group . Patients evaluate weekly first 10 week biweekly thereafter .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Zalcitabine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Aerosolized pentamidine ( 300 mg every 4 week ) Pneumocystis carinii pneumonia ( PCP ) prophylaxis . Neuroleptics , benzodiazepine , antidepressant patient stable chronic treatment &gt; 1 month . Low dose benzodiazepine low dose antidepressant . Drugs unlikely cause increase toxicity either study drug unlikely cause peripheral neuropathy . Drugs little nephrotoxicity , hepatotoxicity , cytotoxicity patient take tolerate well . Acyclovir ( 600 mg/kg/day ) 21 day . Ketoconazole ( 400 mg/day ) Nystatin . Lowdose acetaminophen nonsteroidal antiinflammatory agent . Isoniazid patient evidence peripheral neuropathy entry patient take 50 mg/day pyridoxine concomitantly isoniazid . Allowed interruption study medication 21 day per episode total 42 day study : Drugs could cause serious additive toxicity coadministered either study medication treatment acute intercurrent illness opportunistic infection , include : Acyclovir ( &lt; 600 mg/day ) , fluconazole , systemic pentamidine , foscarnet , pyrimethamine , triple sulfa , ansamycin , ganciclovir , trimethoprim / sulfamethoxazole . Patients must diagnosis AIDS advance AIDS relate complex ( ARC ) . At least 20 percent patient must consistently positive serum HIV p24 antigen ( = &gt; 70 pg/ml ) define Abbott HIV antigen test , two separate occasion least 72 hour apart . Patients find screening temperature &gt; 38.5 degree C evaluate possibility occult opportunistic bacterial infection neoplasm . If complete evaluation reveals infection , enter . If evaluation unrevealing , may enter evaluation complete mycobacterial culture still pending . Patients history unexplained temperature &gt; 38.5 degree C evaluate and/or afebrile ( temperature &lt; 38.0 degree C ) 2 week prior study entry . Allowed : Kaposi 's sarcoma specifically exclude , basal cell carcinoma skin situ carcinoma cervix . Current positive venereal disease research label ( VDRL ) fluorescent treponemal antibody ( FTA ) treat asymptomatic neurosyphilis . Prior Medication : Allowed : Drugs cause peripheral neuropathy drug could cause significant increase toxicity zidovudine ( AZT ) dideoxycytidine ( ddC ) include experimental drug therapy drug complete patient stable 14 day . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Active AIDS defining opportunistic infection active intercurrent illness exclude ongoing treatment require use exclude concomitant medication . Patients symptomatic visceral Kaposi 's sarcoma ( KS ) , progression KS within month prior entry study , current neoplasm specifically allow . Severe AIDS dementia complex define score &lt; 23 MiniMental State Exam . Signs , symptom , history peripheral neuropathy . Significant cardiac disease , define history ventricular arrhythmia require medication , prior myocardial infarct , history angina ischemia change ECG ( electrocardiography ) . Requiring &gt; 2 week acyclovir therapy &gt; 600 mg/day . Current positive venereal disease research label ( VDRL ) fluorescent treponemal antibody ( FTA ) specifically allow . Significant liver disease . Concurrent Medication : Excluded : Drugs cause peripheral neuropathy : chloramphenicol , cisplatinum , iodoquinol , dapsone , phenytoin , disulfiram , ethionamide , glutethimide , gold , hydralazine , ribavirin , metronidazole , vincristine , nitrofurantoin . Drugs could cause significant increase toxicity zidovudine ( AZT ) dideoxycytidine ( ddC ) , include experimental drug specifically allow . Drugs could cause seizure change mental status neurological examination . Concurrent Treatment : Excluded : Transfusion dependency . Patients follow exclude : Active AIDS defining opportunistic infection active intercurrent illness ongoing treatment require use exclude concomitant medication . Symptomatic visceral Kaposi 's sarcoma ( KS ) , progression KS within month prior study entry , current neoplasm specifically allow . Severe AIDS dementia complex define score &lt; 23 MiniMental State Exam . Signs , symptom , history peripheral neuropathy . Unwilling unable sign inform consent . Prior Medication : Excluded : Zidovudine ( AZT ) , dideoxycytidine ( ddC ) , antiretroviral nucleoside analog . Excluded within 90 day study entry : Any experimental drug include fluconazole , ganciclovir , foscarnet , erythropoietin , ribavirin . Excluded within 90 day study entry : Drugs cause significant nephrotoxicity significant hepatotoxicity . Drugs could cause peripheral neuropathy include phenytoin , hydralazine , metronidazole , nitrofurantoin . Systemic corticosteroid immunomodulators include interferon interleukin . Prior Treatment : Excluded within 30 day study entry : Radiation therapy . Active substance alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 1994</verification_date>
	<keyword>Zalcitabine</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
</DOC>